FIELD: medicine, pharmacology, pharmacy.
SUBSTANCE: invention relates to formulations comprising heparin as an active component and a base consisting of lipid and polymeric components for oral using. The lipid component is able preferably to enhance effect of the main component while the polymeric component possesses ability to dissolving or swelling, and at least part of the lipid component is incorporated into the polymeric matrix being in the molecular-dispersed state. Invention provides the sufficient complete absorption of active substance in digestive tract after its oral intake.
EFFECT: valuable properties of formulation.
9 cl, 2 dwg, 8 ex
| Title | Year | Author | Number |
|---|---|---|---|
| COMPOSITION CONTAINING PHENOFIBRIN ACID, ITS PHYSIOLOGICALLY ACCEPTABLE SALT OR DERIVATIVE | 2003 |
|
RU2356549C2 |
| OBTAINING SOLID MEASURED FORMS USING CROSS-LINKED NON-THERMOPLASTIC CARRIER | 2003 |
|
RU2344809C2 |
| COMPOSITION CONTAINING FENOFIBRIC ACID OR PHYSIOLOGICALLY ACCEPTABLE SALT THEREOF, AND CAPSULE CONTAINING COMPOSITION | 2008 |
|
RU2500398C2 |
| SOLID MEDICINAL FORMS PREPARING BY EXTRUSION OF ISOMALT-CONTAINING POLYMER MELT AND ACTIVE SUBSTANCE | 1996 |
|
RU2197228C2 |
| PHARMACEUTICALLY ACCEPTABLE SOLUBILISING COMPOSITION AND PHARMACEUTICAL DOSAGE FORM CONTAINING IT | 2007 |
|
RU2469708C2 |
| PHARMACEUTICAL DOSED FORM, CONTAINING POLYMER CARRIER COMPOSITION | 2009 |
|
RU2519679C9 |
| SOLID, PARTIALLY OR FULLY FROTHED PREPARATIONS OF ACTIVE COMPONENT | 1997 |
|
RU2200004C2 |
| DELIVERY SYSTEM FOR EXTENDED RELEASE OF CALCIUM CHANNEL BLOCKER | 2010 |
|
RU2575839C2 |
| COMPOSITION AND DOSAGE FORM CONTAINING SOLID OR SEMISOLID MATRIX | 2006 |
|
RU2423997C9 |
| CATALYTIC EXTRUDED, SOLID HONEYCOMB BODY | 2015 |
|
RU2671498C2 |
